Objective To describe the frequency of mutations in DNA-repair genes in a southwestern Colombian population. Methods We have designed an observational study, including 162 people from all ages from southwest Colombia. We have extracted and collected their DNA in filters. We have immersed the DNA in a phosphate buffer along with DNeasy package (Thermo Fisher
Introduction
Prostate cancer (PCa) is the most frequent malignant neoplasia diagnosed in men, considering developing countries and the developed ones (excluding skin cancer); besides, it is one of the main causes of death. [1] [2] [3] This condition has a high incidence and prevalence; however, it is possible to find a substantial variation according to the geographic location and to some ethnic groups; 4 for example: in Asian countries like China, PCa has a lower incidence, while in North America, especially in Afro-American individuals, the incidence is higher. [5] [6] [7] Additionally, having a first-grade relative with PCa, the risk is increased by two, and with two relatives, the risk increases five times (OR 2 years 5 respectively).
8
Another important factor is the general classification as sporadic versus familiar PCa, 6 being the latter the most frequently associated with the onset of the disease at early ages (45 years old) in members from the same family. Familiar Pca has been reported as frequent as 15%, while in sporadic PCa, the genetic material is damaged by environmental exposition to different factors during the lifetime (epigenetics), and its prevalence could be as high as between 80 and 90%. 6, 9 Prostate cancer is known as one of the most inherited cancers around the world (almost 50%); accordingly, it increases the autosomal dominant cancer predisposition.
10,11
Mutations in DNA-repair genes such as BRCA2 DNA repair associated (BRCA2), BRCA1 DNA repair associated (BRCA1), checkpoint kinase 2 [CHEK2], homeobox protein Hox-B13 (HOXB13), nibrin (NBN), and a series of single nucleotide polymorphisms (SNPs) 8 have been linked to PCa and have been used as biomarkers for PCa to predict clinical outcomes in a population. 8, [12] [13] [14] According to this intention, researchers need to continue studying genomic variants in different populations due to the pathological and genomic diversity. Until now, there are no studies about genomic diversity regarding the risk for this inherited condition in a southwestern Colombian population (Nariño, Cauca, Putumayo, and Valle -which corresponds to 18% of the Colombian population). To consolidate the knowledge about this clinical condition, we need to translate information about mutations from similar predisposing populations to germline cancers to serve as sentinels to identify families with a high risk of developing this condition. The previous could serve to enable an early diagnosis in order to perform an intervention according to the individual genotype, which nowadays focuses on personalized medicine as a standard way to diagnose and to treat.
The objective of the present study was to describe the frequency of mutations in DNA-repair genes in a southwestern Colombian population.
Methods
We have designed an observational descriptive design that took place from 2014 to 2016. We have included people located in Southwest Colombia (Nariño, Cauca, Putumayo, and Valle) from all ages, multiracial, and coming from the public and private health systems. We have only excluded patients with cancer.
Sample Size
According to the expected frequency for hereditary PCa (15%), alfa 5% and an expected error of 5%, the calculated sample size was 162 people, and the sample selection was by convenience.
Métodos Diseñamos un estudio observacional que incluyó a 162 personas del suroccidente de Colombia de todas las edades. Hemos extraído y recogido el ADN en filtros. Los sumergimos en tampón fosfato junto con el paquete DNeasy (Thermo Fisher Scientific 
DNA Extraction
Each patient underwent blood extraction to obtain the DNA. All of the drops were collected in filter paper until they dried. These filters were immersed in phosphate buffer along with the DNeasy package (Thermo Fisher Scientific, Waltham, MA, USA). Each extraction was quantified and quality-verified to continue the sequencing processing.
Sequencing Protocol
The DNA aliquots from each sample underwent a preparation process with the TruSeq Exome Library Prep (Illumina, Inc. San Diego, CA, USA), then the obtained libraries were normalized to be sequenced using the TruSeq Rapid Exome (Illumina, Inc. San Diego, CA, USA). The normalized fragments with their corresponding adaptors for sequencing were charged in the HiSeq2500 system (Illumina, Inc. San Diego, CA, USA).
We sequenced the full exome and identified the associated variants, specifically the SNPs for 12 The present project accomplished all of the ethical international standards. Descriptive statistics were performed with the R software (The R Foundation for Statistical Computing, Vienna, Austria), 16 and the results are shown in frequency tables for each gene and its associated variants. We finally searched the variants in the following public databases: Exome Aggregation Consortium (ExAC),
17
PharmGKB, 18 Clinvar, 19 and Ensemble, 20 to look for some pattern to use the variants we found as markers.
Results
The Frequency of Mutated Genes 
Associated Variants
The missense and stop variants associated with these 12 genes were present in 22% (2043 data) and in 0.13% (12 data), respectively [►Table 1]. On the other hand, the ATM, BRCA1, BRCA2, and PSM2 genes were the most frequently associated with missense variants (247, 445, 490 and 289 data, The existence of SNPs for these genes further increases the risk, and even could be used as a prognostic biomarker for this condition. 21 Additionally, observing a germline mutation in some DNA-repair genes provides information to patients to look for counseling, to identify predisposition to cancer and, perhaps, to initiate interventions to reduce the risk.
11
Regarding the frequency of these genes, Pritchard et al recently published a paper on patients with metastatic PCa from different series (the United Kingdom and the United States);
11 however, it is important to compare some of the results: the most frequently mutated gene was BRCA2 (5.35%) followed by CHEK2 (1.87%), and the 3 rd was ATM (1.59%). BRCA1
was present in 0.87% of the samples, while genes such as MSH2, NBN, MSH2, MSH6, and PMS2 had a lower frequency (0.14%, 0.29%, 0.14%, 0.14%, and 0.29%, respectively). The HOXB13 gene was not assessed in these series. These results are lower than ours, and we might expect to have a higher frequency, coming from data from metastatic patients. 23 However, these data do not explain these results, since there are no previous studies that described the frequency of these genes and their variants. Pilié et al 24 published another important study to be discussed. This study was not about the frequency of genes, but it identified genes associated with PCa and other concomitant tumors (at least one additional tumor). They also found similar germline genes: BRCA2, ATM, MLH1, BRCA1, CHEK2, and HOXB13, although they found 10% of pathogenic or likely pathogenic mutations in cancer-predisposing genes. They found 525 missense, 7 frameshit, 5 in-frame coding insertion or deletions, and 2 nonsense variants (rs80359440, rs80359515, rs61757642, rs587781658, rs373226793, rs180177143, rs759113408, rs17879961, and rs138213197). In contrast, in the present study, we found a higher frequency of this type of variants and none of the SNPs they reported. In our study, which is identified as the first study of this type in southwestern Colombia, the BRCA2 gene was the most frequently mutated, and it has been considered one of the few genes that confer a high risk of suffering from PCa and other conditions.
3,6,25,26
The BRCA2 gene has an important role in the repair of double-strand DNA breaks, functioning by regulating the intracellular transport and the activity of RAD51, a critical protein in homologous recombination. [27] [28] [29] The most frequent variants found for this gene, such as rs169547, rs206075, rs206076, and rs9534262, are similar to those found in other studies. 30, 31 These have been considered benign mutations 32-34 -the first three were reported in Colombia by Arias-blanco et al 35 -and rs9534262 was considered a deletion-type mutation with an unknown clinical relevance according to D'Argenio et al, 33 although it is registered as benign according to ClinVar. Rs9534262 seems to be a quantitative trait locus (QTL) of significant importance, since it regulates the levels of the alternative transcripts of the BRCA2 gene.
36
The 2 nd most commonly mutated gene was ATM, which exerts control in cell division. When detecting damage in the genetic material, it leads to either cell cycle arrest, to DNA repair, or to apoptosis. [37] [38] [39] In addition, it can be considered as the main transducer in the repair process of the rupture of the doublestrand, in which it recruits and cooperates with other sensor proteins, such as 53BP1 (p53 binding protein) and BRCA1. The BRCA1 gene is the third mutated gene found and associated with an increased risk of sporadic PCa (3.5 times), while for germline mutations in this gene, while only 0.44% of PCa for germline mutations. Another important gene found in the present study was NBN, which is a component of the protein complex hMRE11/ hRad50/NBN that participates in the initiation of a response to DNA damage and is linked to the repair of double-strand rupture. [46] [47] [48] This acts in the nonhomologous junction pathway as a DNA damage sensor and in the homologous recombination pathway, participating in DNA repair and in the cell cycle checkpoint in the S phase. 48 The rs709816 polymorphism is one of its most frequent variant, which has been associated with bladder cancer
48
; another one was rs3736639, which has been found at a slightly higher frequency in patients with leukemia.
46
On the other hand, the rs1805794 polymorphism presents positive association with different types of cancer, such as bladder, 49, 50 polymorphism, the altered nucleotide may affect the stability of the mRNA, the splicing, or the transduction rate.
48
Additionally, rs169547 (BRCA2), rs9534262 (BRCA2), rs659243 (ATM), rs228589 (ATM), rs1042522 (TP53), and rs2228006 (PMS2) had the higher Latino allele frequency, and some of them showed coincidence with a higher MAF. This would be the first description of these kinds of SNPs for the Colombian population that leads to studying the way to work with them as a network as biomarkers for PCa.
Strengths and Limitations
This is the first study performed in the southwestern Colombian population, which is extremely important to characterize our population and to begin to recognize the risk for developing PCa. The quality of the samples, the methods we followed, and the quality and the analysis performed with the data are other important issues to highlight from our study.
Regarding the limitations, we could declare that most of the variants found in the present study are considered as benign. Nonetheless, it is important to go deeper to analyze longitudinally these data and to obtain the real risk in this population. Perhaps another important limitation could be that the extrapolation of these data is limited to people with similar characteristics in southwest Colombia.
Conclusions
To conclude, the BRCA2, ATM, BRCA1, and NBN DNA-repair genes were the most frequently mutated in this southwestern Colombian population. Additionally, there were nonpathological variants, such as rs169547, rs206075, rs206076, and rs9534262, and some other variants, such as rs799917, rs3736639, rs1061302, and rs1805794, which were associated with the NBN gene, which is highly linked to PCa.
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